Thought Leadership

A weekly publication that provides in-depth analysis of the trends affecting health insurers’ market share, benefit designs, profitability and regulation, and the strategies they use to respond.

Benefits:

• In-depth analysis of market share, profitability, and regulation trends.
• Strategies on how health insurers can respond to market conditions.
• Strategic business, financial and regulatory analysis relevant to health insurers, pharmaceutical companies, health systems, benefits managers, and analysts.

A biweekly publication that covers pharmacy benefit design and strategy for health plans, employers, PBMs and pharmaceutical companies.

Benefits:

• Pharmacy reimbursement business strategies and analysis for health plans, employers, PBMs and pharmaceutical companies.
• Exclusive data from AIS Health and MMIT, including indication-specific drug trends, coverage policies and copay/coinsurance levels.
• Drug trends for a specific class, employer attitudes toward pharmacy benefit management tools and copay/coinsurance levels.

A biweekly publication that discusses strategies and analysis of Medicare Advantage, Medicare Part D and managed Medicaid benefit design and reimbursement.

Benefits:

• In-depth articles with multiple perspectives that address major catalysts in the Medicare Advantage, managed Medicaid, Medicare Part D and dual-eligible markets.
• Industry surveillance, news and exclusive AIS Health data.
• Customized content for health plans, trade groups, consumer advocates, pharmacy benefit managers, and revenue cycle product vendors.

A monthly publication that offers strategic business information about specialty drugs, related devices and tests, and therapeutic areas for pharmaceutical companies, pharmacy directors, MCOs, PBMs, industry consultants and clinicians.

Benefits:

• Strategic information for pharmaceutical companies, pharmacy directors, MCOs, PBMs, industry consultants and clinicians.
• In-depth articles with multiple perspectives, addressing major catalysts and ongoing topics of interest, such as specialty pharmacy network strategies, new FDA-approved specialty products, payer management strategies for drugs and diseases and M&A trends impacting specialty pharmacy stakeholders.
• Data and analysis of specialty drug trend and spend, cost projections and pipeline data.